TUBGCP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.752200E-01
Normal-vs-Stage2
5.975400E-01
Normal-vs-Stage3
1.237610E-01
Normal-vs-Stage4
4.112000E-01
Stage1-vs-Stage2
5.574600E-01
Stage1-vs-Stage3
4.436500E-03
Stage1-vs-Stage4
8.005400E-01
Stage2-vs-Stage3
8.655800E-02
Stage2-vs-Stage4
4.493400E-01
Stage3-vs-Stage4
1.423800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.121800E-01
Normal-vs-AfricanAmerican
3.524000E-01
Normal-vs-Asian
9.362600E-01
Caucasian-vs-AfricanAmerican
2.752200E-01
Caucasian-vs-Asian
4.363600E-01
AfricanAmerican-vs-Asian
2.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.209200E-01
Normal-vs-Female
5.934200E-01
Male-vs-Female
8.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.454570E-01
Normal-vs-Age(41-60Yrs)
2.977800E-01
Normal-vs-Age(61-80Yrs)
8.023000E-01
Normal-vs-Age(81-100Yrs)
9.935600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.647000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.379800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.017760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.217100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.914400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.346800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.793800E-01
Normal-vs-Daily Drinker
9.525400E-01
Normal-vs-Weekly Drinker
8.749200E-01
Normal-vs-Occasional Drinker
3.787800E-01
Normal-vs-Social Drinker
3.923600E-01
Non Drinker-vs-Daily Drinker
6.553600E-01
Non Drinker-vs-Weekly Drinker
4.227200E-01
Non Drinker-vs-Occasional Drinker
1.669960E-01
Non Drinker-vs-Social Drinker
1.798970E-01
Daily Drinker-vs-Weekly Drinker
7.133800E-01
Daily Drinker-vs-Occasional Drinker
1.057180E-01
Daily Drinker-vs-Social Drinker
1.195840E-01
Weekly Drinker-vs-Occasional Drinker
6.940300E-02
Weekly Drinker-vs-Social Drinker
8.074400E-02
Occasional Drinker-vs-Social Drinker
9.608600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.807600E-02
Normal-vs-Grade 2
2.902200E-02
Normal-vs-Grade 3
5.036200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.566400E-01
Grade 1-vs-Grade 3
6.899800E-02
Grade 1-vs-Grade 4
8.807600E-02
Grade 2-vs-Grade 3
5.275500E-02
Grade 2-vs-Grade 4
2.902200E-02
Grade 3-vs-Grade 4
5.036200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.345000E-01
Normal-vs-NonDiabetic
5.807800E-01
Diabetic-vs-NonDiabetic
1.242230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.800000E-01
Normal-vs-NoPancreatitis
6.226000E-01
Pancreatitis-vs-NoPancreatitis
9.945200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.771200E-01
Normal-vs-N1
5.638400E-01
N0-vs-N1
6.491600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.871400E-01
Normal-vs-TP53-NonMutant
4.686400E-01
TP53-Mutant-vs-TP53-NonMutant
9.291800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
